Primary Site >> Stomach Cancer

Gene >> GGH

Journal: Br J Cancer. 1990 Oct;62(4):627-30.
Title: Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.
Author: Klijn, J G|Hoff, A M|Planting, A S|Verweij, J|Kok, T|Lamberts, S W|Portengen, H|Foekens, J A
PMID: 1977468
Journal: Int J Clin Oncol. 2008 Dec;13(6):498-503.
Title: Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracil-responsive subgroup?
Author: Iacopetta, Barry|Kawakami, Kazuyuki|Watanabe, Toshiaki
PMID: 19093176
Journal: Gastric Cancer. 2017 Mar;20(2):379-386.
Title: Surgical resection of hepatic metastases from gastric cancer: outcomes from national series in England.
Author: Markar, Sheraz R|Mackenzie, Hugh|Mikhail, Sameh|Mughal, Muntzer|Preston, Shaun R|Maynard, Nick D|Faiz, Omar|Hanna, George B
PMID: 26939792
Journal: Oncotarget. 2017 Mar 4;8(34):57574-57582.
Title: TOP2A, GGH, and PECAM1 are associated with hematogenous, lymph node, and peritoneal recurrence in stage II/III gastric cancer patients enrolled in the ACTS-GC study.
Author: Terashima, Masanori|Ichikawa, Wataru|Ochiai, Atsushi|Kitada, Koji|Kurahashi, Issei|Sakuramoto, Shinichi|Katai, Hitoshi|Sano, Takeshi|Imamura, Hiroshi|Sasako, Mitsuru
PMID: 28915696